PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding PDS Biotechnology Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 53 | 52 | −1 |
| Shares | 5.93M | 5.37M | −554.9K (−9.4%) |
| Value | $36.7M | $19.7M | −$17.0M (−46.3%) |
New holders (11)
Institutions that held PDS Biotechnology Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 194,500 | $710.0K | 0.00% |
| Millennium Management LLC | 150,497 | $549.0K | 0.00% |
| Bank of Montreal | 43,500 | $249.0K | 0.00% |
| Virtu Financial LLC | 47,326 | $173.0K | 0.01% |
| Occudo Quantitative Strategies LP | 22,085 | $81.0K | 0.01% |
| XTX Topco Ltd | 21,085 | $77.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 15,700 | $57.0K | 0.00% |
| Simplex Trading, LLC | 13,426 | $49.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 3,779 | $14.0K | 0.01% |
| US Bancorp | 1,084 | $4.00K | 0.00% |
| Truvestments Capital LLC | 655 | $2.00K | 0.00% |
Sold out (12)
Institutions that held PDS Biotechnology Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| AIGH Capital Management LLC | 282,609 | $1.75M |
| Fred Alger Management, LLC | 119,082 | $737.0K |
| D. E. Shaw & Co., Inc. | 83,112 | $514.0K |
| Worth Venture Partners, LLC | 70,378 | $436.0K |
| Goldman Sachs Group Inc | 29,752 | $184.0K |
| Alps Advisors Inc | 29,221 | $181.0K |
| Gsa Capital Partners LLP | 14,321 | $89.0K |
| Qube Research & Technologies Ltd | 13,862 | $86.0K |
| Ikarian Capital, LLC | 3,672 | $22.0K |
| UBS Group AG | 2,499 | $15.0K |
| Rockefeller Capital Management L.P. | 955 | $5.00K |
| Tower Research Capital LLC (TRC) | 124 | $1.00K |